Sattva Neelapu Selected Research

Thrombocytopenia (Thrombopenia)

1/2018	Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
12/2013	Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sattva Neelapu Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 05/2006
10	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 05/2006
9	Lymphoma (Lymphomas) 09/2023 - 08/2012
8	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 02/2008
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 11/2009
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 12/2013
3	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 11/2012
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2007 - 05/2006
2	Infections 02/2024 - 12/2013
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021 - 01/2019
2	Neutropenia 01/2018 - 12/2013
2	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2013
2	Anemia 07/2017 - 12/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2013 - 08/2007
1	Invasive Pulmonary Aspergillosis 02/2024
1	Aspergillosis 02/2024
1	Opportunistic Infections (Opportunistic Infection) 02/2024
1	Plasmacytoma 09/2023
1	Cutaneous Lupus Erythematosus 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Adenocarcinoma 01/2020
1	Cytokine Release Syndrome 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Disease Progression 11/2018
1	Second Primary Neoplasms (Neoplasms, Second) 11/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Fever (Fevers) 01/2018
1	Hypothyroidism 01/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2015
1	Fatigue 12/2013
1	Dyspnea (Shortness of Breath) 12/2013

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 01/2023 - 08/2007
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2013
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 12/2013
5	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 12/2013
4	Prednisone (Sone)FDA LinkGeneric 12/2018 - 12/2013
3	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2020
3	VaccinesIBA 09/2023 - 05/2006
3	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 05/2015
2	ibrutinibIBA 01/2023 - 11/2018
2	Monoclonal AntibodiesIBA 01/2022 - 02/2007
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2015
2	CytokinesIBA 01/2020 - 12/2013
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 04/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 12/2013
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 12/2013
2	PanobinostatIBA 01/2018 - 12/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 12/2013
2	AntigensIBA 09/2013 - 05/2006
2	Gemcitabine FDA Link 10/2011 - 02/2008
1	RNA (Ribonucleic Acid)IBA 05/2024
1	axicabtagene ciloleucelIBA 05/2024
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	UbiquitinIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	venetoclaxIBA 01/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2020
1	acalabrutinibIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Ifosfamide FDA LinkGeneric 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	IceIBA 01/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Texas redIBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	MelatoninIBA 01/2017
1	MK 2206IBA 11/2015
1	Everolimus FDA Link 12/2013
1	LigandsIBA 09/2013
1	HLA-A*02:01 antigenIBA 09/2013
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 11/2012
1	Janus Kinase 2IBA 11/2012
1	coltuximab ravtansineIBA 08/2012
1	Immunoconjugates (Immunoconjugate)IBA 08/2012
1	Histone Deacetylase InhibitorsIBA 12/2011
1	mocetinostatIBA 12/2011
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2011
1	Yttrium-90IBA 11/2009
1	ibritumomab tiuxetan (Zevalin)FDA Link 11/2009
1	denileukin diftitox (Ontak)FDA Link 08/2007
1	Cancer VaccinesIBA 02/2007
1	IpilimumabIBA 02/2007
1	PolyethyleneimineIBA 07/2006

Therapy/Procedure

11	Radiotherapy 01/2021 - 05/2015
8	Therapeutics 01/2022 - 10/2011
6	Drug Therapy (Chemotherapy) 02/2024 - 12/2013
2	Aftercare (After-Treatment) 05/2024 - 12/2013
2	Stem Cell Transplantation 01/2018 - 12/2011
1	Hematopoietic Stem Cell Transplantation 02/2024
1	Drug Tapering 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Immunotherapy 09/2013
1	Intravenous Infusions 08/2012